申请人:Hokuriku Seiyaku Co., Ltd.
公开号:US06518265B1
公开(公告)日:2003-02-11
1H-Imidazopyridine derivatives represented by the following general formula or salts thereof:
wherein R1 represents hydrogen atom, hydroxyl group, an alkyl group, a cycloalkyl group, styryl group, or an aryl group; R2 represents hydrogen atom, an alkyl group, a halogen atom, hydroxyl group, amino group, a cyclic amino group, or phenoxy group; ring A represents a homocyclic or heterocyclic ring which may be substituted; R3 represents a saturated nitrogen-containing heterocyclic group; and m represents an integer of from 0 to 3. The derivatives have excellent inhibitory actions against production of TNF or IL-1 and are extremely useful as preventive or therapeutic agents for diseases in which a cytokine is mediated.
1H-咪唑吡啶衍生物由以下一般式或其盐所代表:其中R1代表氢原子、羟基、烷基、环烷基、苯乙烯基或芳基;R2代表氢原子、烷基、卤素原子、羟基、氨基、环氨基或苯氧基;环A代表可能被取代的同环或异环环;R3代表饱和氮含杂环基;m代表0至3的整数。这些衍生物对TNF或IL-1的产生具有出色的抑制作用,并且在细胞因子介导的疾病的预防或治疗剂中非常有用。